Drug Profile
Rifampicin - AlphaRx
Alternative Names: Rifampicin nanoparticles - AlphaRx; RifamsolinLatest Information Update: 29 Dec 2021
Price :
$50
*
At a glance
- Originator AlphaRx
- Class Antibacterials; Antineoplastics; Antituberculars; Hepatoprotectants; Rifamycins
- Mechanism of Action DNA-directed RNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Tuberculosis
Most Recent Events
- 05 Jul 2011 Discontinued - Preclinical for Tuberculosis in Canada (PO)
- 27 May 2008 AlphaRx establishes CRADA with US Army for the development of antibacterial nanoparticles in severe intracellular bacterial infections
- 07 Feb 2005 Preclinical trials in Tuberculosis in Canada (PO)